Back |
home / stock / phguf / phguf message board
Subject | By | Source | When |
---|---|---|---|
Pharming Group Is A Good Alternative! 1y Target | dennisv | investorshub | 02/16/2017 11:17:26 AM |
Keep Your Eyes Open! | dennisv | investorshub | 01/24/2017 1:33:02 PM |
Pharming Group Solid Base Built To Support Growing. | dennisv | investorshub | 01/22/2017 4:39:19 PM |
https://finance.yahoo.com/quote/PHARM.AS/community?p=PHARM.AS | dennisv | investorshub | 01/16/2017 1:44:39 PM |
To Be Continued! | dennisv | investorshub | 01/16/2017 1:14:14 PM |
Pharming Group Goes Well! | dennisv | investorshub | 01/09/2017 3:22:42 PM |
FDA Approval Of RUCONEST For Acute Angioedema Attacks | xr_biotech_consult | investorshub | 07/17/2014 6:49:15 AM |
Stock Tracker: Latest Pharming Grp Nv Leid (PHGUF) Headlines Pharming Reports On Preliminary Financi | Stock_Tracker | investorshangout | 03/11/2014 4:06:08 AM |
chartguy89: PHGUF 0.80 Stock Charts $PHGUF 1 Month Chart | chartguy89 | investorshangout | 03/09/2014 9:57:08 AM |
chartguy89: PHGUF Stock Charts Last: -0.03 Friday, February 28, 2014 at 11:43:17 PM $PHGUF 1 | chartguy89 | investorshangout | 03/01/2014 4:43:28 AM |
$PHGUF: BLA Filed For Ruconest, As Anticipated; Reiterate Buy | xr_biotech_consult | investorshub | 04/25/2013 5:35:59 PM |
Santarus and Pharming Announce Submission of RUCONEST Biologics | plumo | investorshub | 04/17/2013 3:16:21 PM |
Santarus and Pharming Announce Submission of RUCONEST Biologics | plumo | investorshub | 04/17/2013 3:16:07 PM |
so this must be around the corner : | xr_biotech_consult | investorshub | 03/03/2013 9:59:21 AM |
after R/S new Target 1.60 | xr_biotech_consult | investorshub | 03/03/2013 9:53:42 AM |
5. Mrz 2013 R/S 1/10 | xr_biotech_consult | investorshub | 03/03/2013 9:52:53 AM |
TARGET 0.16 by ROTH Capital Partners | xr_biotech_consult | investorshub | 01/03/2013 12:16:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Pharming Group Nv Ord Company Name:
PHGUF Stock Symbol:
OTCMKTS Market:
Pharming Group Nv Ord Website:
Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) second quarter and first half 2024 financial results, for the period ended June 30, on Thursday, August 1, 2024. ...
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of June: Jefferies Healthcare Conference, New ...
Leiden, the Netherlands, May 21, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved. The shareholders approved the proposa...